By Kelly Knaub ( December 2, 2015, 11:05 AM EST) -- The Federal Circuit on Wednesday denied a request to rehear en banc a decision that Sequenom Inc.'s patent for a fetal DNA test is patent-ineligible because it is directed to a natural phenomenon, based on the framework established by the U.S. Supreme Court's Myriad and Mayo decisions....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.